Multimodality Treatment Including Triplet Regimen as First-Line Chemotherapy May Improve Prognosis of Serum AFP-Elevated Gastric Cancer with Liver Metastasis

Table 3

Comparison of ORR of different chemotherapy regimens between two groups.

Regimens	AFP ≥ 20 ng/ml	AFP < 20 ng/ml
Platinum/taxane-based doublet regimen
PR	21 (38.2%)	91 (56.9%)	0.013
SD + PD	34 (61.8%)	69 (43.1%)
Triplet regimen
PR	6 (66.7%)	8 (66.7%)	0.676
SD + PD	3 (33.3%)	4 (33.3%)